Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
ClinicalTrials.gov study NCT06365671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors
ClinicalTrials.gov study NCT06976437. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma
ClinicalTrials.gov study NCT00316511. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )
ClinicalTrials.gov study NCT07032324. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05800405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT00944905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01470456. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT01178645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
ClinicalTrials.gov study NCT04887012. IPD Sharing: NO. Countries: 1. Publications: 0.
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT06343311. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT04861779. IPD Sharing: Not stated. Countries: 2. Publications: 0.
CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma
ClinicalTrials.gov study NCT04649983. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06935136. IPD Sharing: NO. Countries: 1. Publications: 0.
Regulatory B Cells and Chronic Immune Thrombocytopenia
ClinicalTrials.gov study NCT02891109. IPD Sharing: NO. Countries: 1. Publications: 0.
Nivolumab and Pomalidomide in Treating Patients With Relapsed or Refractory Central Nervous System Diffuse Large B Cell Lymphoma or Primary Vitreoretinal Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT03798314. IPD Sharing: Not stated. Countries: 1. Publications: 0.
a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT02846584. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL
ClinicalTrials.gov study NCT04156659. IPD Sharing: YES. Countries: 0. Publications: 0.
Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02992522. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies
ClinicalTrials.gov study NCT05487651. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)
ClinicalTrials.gov study NCT03964090. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.